Product Status and Market Potential
Beyond Air Pipeline & Market Size
Product | Indication | Development Status |
Key Dates* | US Sales Potential** |
Worldwide Sales Potential** |
---|---|---|---|---|---|
LungFit PRO | Bronchiolitis | 3 Pilot studies complete Pivotal-ready |
Pivotal Starts 4Q21 (pandemic permitting) US Launch 2023 |
>$500M Beyond Air to commercialize |
>$1.2B |
*All dates are based on projections and appropriate financing, anticipated first launch on global basis pending appropriate regulatory approvals
**All figures are Company estimates for peak year sales: Global Sales Potential includes US Sales Potential